Metabolic alteration in healthy men with first degree type 2 diabetic relatives

2013 ◽  
Vol 154 (5) ◽  
pp. 178-186 ◽  
Author(s):  
József Pauer ◽  
Attila Fék ◽  
Barbara Buday ◽  
Botond Literáti-Nagy ◽  
Péter Pach ◽  
...  

Introduction: The recognition of prediabetic patients with the genetic risk of type 2 diabetes is very important as prediabetes is the last stage when manifestation of diabetes could be prevented by life style modification or drug intervention. This suggests the need for diagnostic processes to trace the risk of patients in time. Aims: The authors looked for metabolic differences between age and BMI in adjusted healthy men with or without first degree type 2 diabetic relatives. Methods: The study included 73 healthy men (21 with and 52 without) first-degree relatives with type 2 diabetes. Results: Total body and muscle tissue glucose utilization, glucose tolerance did not differ between the two groups, but free fatty acid levels were not suppressed by glucose load in subjects with diabetic relatives. In addition the body fat content, leptin and IL-6 levels were higher, while adiponectin and the free fatty acid/adiponectin ratio were significantly lover in healthy men with diabetic relatives. In this group HDL cholesterol, and the large buoyant LDL fraction were lower whereas the high density LDL – small molecular lipid fraction was higher than those measured in subjects without diabetic relatives. Conclusions: These data suggest that deteriorations of insulin sensitivity and glucose tolerance is preceded by disturbances of fatty acid metabolism. The observed alteration in free fatty acid/adiponectin ratio, and/or the absence of free fatty acid suppression during glucose tolerance tests could be a screening tool for diabetes risk among men. Orv. Hetil., 2013, 154, 178–186.

2018 ◽  
Vol 24 (12) ◽  
pp. 1063-1072 ◽  
Author(s):  
Eiji Kutoh ◽  
Asuka Wada ◽  
Jyunka Hayashi

2001 ◽  
Vol 86 (4) ◽  
pp. 1638-1644
Author(s):  
E. E. Blaak ◽  
B. H. R. Wolffenbuttel ◽  
W. H. M. Saris ◽  
M. M. A. L. Pelsers ◽  
A. J. M. Wagenmakers

2011 ◽  
Vol 34 (10) ◽  
pp. 1613-1618 ◽  
Author(s):  
Kazuko Kojima ◽  
Tsutomu Shimada ◽  
Yasuhiro Nagareda ◽  
Michiru Watanabe ◽  
Junko Ishizaki ◽  
...  

Diabetes ◽  
2003 ◽  
Vol 52 (3) ◽  
pp. 675-681 ◽  
Author(s):  
J. M. Miles ◽  
D. Wooldridge ◽  
W. J. Grellner ◽  
S. Windsor ◽  
W. L. Isley ◽  
...  

2008 ◽  
Vol 54 (1) ◽  
pp. 181-187 ◽  
Author(s):  
Anna Cabré ◽  
Iolanda Lázaro ◽  
Josefa Girona ◽  
Josep M Manzanares ◽  
Francesc Marimón ◽  
...  

Abstract Background: Fatty acid–binding protein 4 (FABP4) has been linked to metabolic syndrome development, diabetes, and arteriosclerosis, but the role of FABP4 in target organ damage has not been assessed. We evaluated whether plasma FABP4 is associated with renal dysfunction in type 2 diabetic patients. Methods: In 263 individuals (161 type 2 diabetic patients and 102 healthy nondiabetic controls), we analyzed the correlation between FABP4 and creatinine or glomerular filtration index (MDRD-GFR) regarding the presence or absence of microalbuminuria. Patients with severe chronic kidney disease (MDRD-GFR <30 mL/min/1.73 m2) or albuminuria were not included. Results: FABP4 concentrations were higher in diabetic patients with MDRD-GFR <60 mL/min/1.73 m2 (P <0.001). We observed a significant, direct correlation between FABP4 and creatinine (r = 0.446, P <0.001) and an inverse correlation between FABP4 and MDRD-GFR (r = −0.511, P <0.001) in type 2 diabetic patients, but not in nondiabetic individuals. These correlations were sustained when only those patients without microalbuminuria were analyzed (r = 0.414, P <0.001 and r = −0.510, P <0.001, respectively). Type 2 diabetic patients with FABP4 in the highest tertile compared with those in the lower tertiles had increased adjusted odds ratios for moderate renal dysfunction [7.5 (95%CI 1.8–30.7), P = 0.005 and 15.3 (3.1–76.4), P = 0.001; respectively], independent of microalbuminuria. Conclusions: High FABP4 plasma concentrations are associated with high plasma creatinine and low MDRD-GFR in patients with type 2 diabetes even in the absence of microalbuminuria or clinically relevant alterations of creatinine and MDRD-GFR values. FABP4 concentrations should be taken into consideration as an early marker of kidney damage in patients with type 2 diabetes.


Sign in / Sign up

Export Citation Format

Share Document